Cargando…
The growing problem of co-treatment with opioids and benzodiazepines
A powerful example of potentially dangerous low value care
Autores principales: | Karaca-Mandic, Pinar, Meara, Ellen, Morden, Nancy E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283389/ https://www.ncbi.nlm.nih.gov/pubmed/28292825 http://dx.doi.org/10.1136/bmj.j1224 |
Ejemplares similares
-
Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016
por: Jeffery, Molly M., et al.
Publicado: (2019) -
Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs
por: Cher, Benjamin A.Y., et al.
Publicado: (2019) -
Provision of Digital Health Technologies for Opioid Use Disorder Treatment by US Health Care Organizations
por: Miller-Rosales, Chris, et al.
Publicado: (2023) -
Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017) -
Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)